IRADIMED CORPORATION— Sankey Diagram
Annual mode · period ending 2026-03-31 · SEC EDGAR
FY2026 - Q4(Jan 26 · Feb 26 · Mar 26)
Total Assets
$114M
↑+12.4% +$13Mvs FY2025
Total Liabilities
$16M
↑+36.0% +$4Mvs FY2025
Equity
$99M
↑+9.4% +$8Mvs FY2025
Cash
$56M
↑+12.0% +$6Mvs FY2025
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $114M | $102M |
| Current Assets | $86M | $75M |
| Cash | $56M | $50M |
| ST Investments | $0 | $0 |
| Receivables | $13M | $13M |
| Inventory | $12M | $11M |
| Other Current | $5M | $2M |
| Non-Current Assets | $28M | $27M |
| PPE | $24M | $20M |
| Goodwill | $0 | $0 |
| Intangibles | $3M | $3M |
| Investments | $0 | $0 |
| Other Non-Current | $456K | $3M |
| Total Liab+Eq | $114M | $102M |
| Current Liab. | $12M | $8M |
| Accounts Payable | $2M | $3M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $3M | $3M |
| Other CL | $7M | $3M |
| Non-Current Liab. | $4M | $3M |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $4M | $3M |
| Equity | $99M | $90M |
| Retained Earnings | $67M | $59M |
| Other Equity | $31M | $31M |
QuarterCharts · SEC EDGAR data · IRMD · Comparing FY2026 vs FY2025